AGP Executive Report
Last update: 12 hours agoHong Kong Health Reform: The Hospital Authority set up an Office for Introducing Innovative Drugs and Medical Devices to speed up adding “new and better” treatments to hospital formularies, with plans to shorten evaluation timelines (including for cancer drugs) by about one-third. Influenza Preparedness: Hong Kong’s Centre for Health Protection lab was designated a WHO Collaborating Centre for the Global Influenza Surveillance and Response System, and it’s hosting international expert meetings on detecting existing and emerging respiratory viruses. Aging & Access in Asia-Pacific: Chinese Taipei pledged USD 1.5 million to APEC’s first dedicated healthcare sub-fund, aimed at strengthening integrated primary care, telemedicine and policy research for aging and chronic disease. Biotech Manufacturing in China: Dark Horse Consulting Group and Altruist Biologics signed an MoU to streamline clinical-to-commercial cGMP biologics manufacturing in China, targeting monoclonal antibodies, bispecifics and ADCs. Nutrition/Gut Health Trend: Coverage highlights fermented foods like sauerkraut as a gut-supporting dietary strategy, pointing to research on lactic acid bacteria and intestinal barrier effects.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
